AAAAAA

   
Results: 1-10 |
Results: 10

Authors: BRUISTEN SM REISS P LOELIGER AE VANSWIETEN P SCHUURMAN R BOUCHER CAB WEVERLING GJ HUISMAN JG
Citation: Sm. Bruisten et al., CELLULAR PROVIRAL HIV TYPE-1 DNA LOAD PERSISTS AFTER LONG-TERM RT-INHIBITOR THERAPY IN HIV TYPE-1 INFECTED PERSONS, AIDS research and human retroviruses, 14(12), 1998, pp. 1053-1058

Authors: BRUISTEN SM FRISSEN PHJ VANSWIETEN P HARRIGAN PR KINGHORN I LARDER B WEIGEL HM DEVRIES E REGEZ RM HENRICHS JH KOOT M HUISMAN JG
Citation: Sm. Bruisten et al., PROSPECTIVE LONGITUDINAL ANALYSIS OF VIRAL LOAD AND SURROGATE MARKERSIN RELATION TO CLINICAL PROGRESSION IN HIV TYPE 1-INFECTED PERSONS, AIDS research and human retroviruses, 13(4), 1997, pp. 327-335

Authors: BRUISTEN SM OUDSHOORN P VANSWIETEN P BOESERNUNNINK B VANAARLE P TONDREAU SP CUYPERS HTM
Citation: Sm. Bruisten et al., STABILITY OF HIV-1 RNA IN BLOOD DURING SPECIMEN HANDLING AND STORAGE PRIOR TO AMPLIFICATION BY NASBA-QT, Journal of virological methods, 67(2), 1997, pp. 199-207

Authors: GROENEVELD PHP KROON FP NIBBERING PH BRUISTEN SM VANSWIETEN P VANFURTH R
Citation: Php. Groeneveld et al., INCREASED PRODUCTION OF NITRIC-OXIDE CORRELATES WITH VIRAL LOAD AND ACTIVATION OF MONONUCLEAR PHAGOCYTES IN HIV-INFECTED PATIENTS, Scandinavian journal of infectious diseases, 28(4), 1996, pp. 341-345

Authors: VANMILLIGEN FJ CRAIG S ROGERS BL VANSWIETEN P AALBERSE RC
Citation: Fj. Vanmilligen et al., DIFFERENCES BETWEEN SPECIFICITIES OF IGE AND IGG4 ANTIBODIES - STUDIES USING RECOMBINANT CHAIN-1 AND CHAIN-2 OF THE MAJOR CAT ALLERGEN FELIS-DOMESTICUS (FEL-D)-I, Clinical and experimental allergy, 25(3), 1995, pp. 247-251

Authors: BRUISTEN S FRISSEN J HUISMAN J WEIGEL H VANSWIETEN P DEVRIES E REGEZ R HARRIGAN R TERSMETTE M REISS P
Citation: S. Bruisten et al., VIRAL LOAD AND SURROGATE MARKERS IN A PROSPECTIVE-STUDY OF ASYMPTOMATIC HIV-1-INFECTED PERSONS, Journal of cellular biochemistry, 1995, pp. 202-202

Authors: STRINGER HAR VANSWIETEN P HEIJNEN HFG SIXMA JJ PANNEKOEK H
Citation: Har. Stringer et al., PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASED FROM ACTIVATED PLATELETS PLAYS A KEY ROLE IN THROMBOLYSIS RESISTANCE - STUDIES WITH THROMBI GENERATED IN THE CHANDLER LOOP, Arteriosclerosis and thrombosis, 14(9), 1994, pp. 1452-1458

Authors: STRINGER HAR VANSWIETEN P HORREVOETS AJG SMILDE A PANNEKOEK H
Citation: Har. Stringer et al., THE ROLE OF THE FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN INITIATION AND PROGRESSION OF THROMBOLYSIS, Thrombosis and haemostasis, 72(6), 1994, pp. 900-905

Authors: VANMILLIGEN FJ VANSWIETEN P AALBERSE RC
Citation: Fj. Vanmilligen et al., IGE AND IGG4 BINDING TO THE OCELOT VARIANT OF THE CAT (FELIS-DOMESTICUS) MAJOR ALLERGEN FEL-D-I, Allergy, 49(5), 1994, pp. 393-394

Authors: STRINGER HAR VANSWIETEN P HEIJNEN HFG SIXMA JJ PANNEKOEK H
Citation: Har. Stringer et al., ON THE FUNCTION OF PAI-1 IN PLATELET-RICH THROMBI PRODUCED IN THE CHANDLER LOOP, Thrombosis and haemostasis, 69(6), 1993, pp. 582-582
Risultati: 1-10 |